Tuesday, October 1, 2013

September 2013 Results

September 2013 Results
Present Plan:
I will contribute $400/mo to the portfolio, aiming for returns of 10% year after year, with increasing dividend income.  I am allowed 30% in growth and speculative stocks at this point in my life.
At present, my immediate plan is to get my model portfolio in place in the dividend growth part of the portfolio.  I still need to trim to positions and add to others, so I expect to make a few trades near term.
 
All dividends are currently being reinvested back into the companies paying the dividend (TGH does not have a reinvestment plan). New cash is used to add to positions or create new ones at $1-2k increments.

Commentary: I've been very happy with the performance of the dividend growth portfolio.  MCD's raise was disappointing, but does not warrant sale consideration.  I am presently considering the sale of both BUD and TGH for separate reasons.  BUD (@ $105) because it appears overvalued and could I could obtain a higher dividend yield elsewhere, TGH (@ $40) because of its financial stability and how it trades.  I'm eyeing JNJ, GIS or perhaps another utility as replacements.

Regarding the "Growth" section of the portfolio, I've been surprised by the way ATRS has seesawed between $4 - 4.50 in the run up to the October PDUFA date, but I've been making decent money writing $5 strike covered calls.  My yield on ATRS YTD is 15.6%.  I love this company's pipeline and prospects and continue to hold it ~20% of my portfolio.  AMRN is a trade that is taking longer to come to fruition than I expected.  I, like most others, still expect a buyout and hopefully one north of $20 if the FDA approves the Anchor indication.  ACTC is the most disappointing.  I am selling this stock at the announcement it is moving into Phase 2 for AMD/SMD.  Management has continued to disappoint and I do not feel this is a name I want to hold for any great period of time.  Lastly, PSTI is going to remain in my portfolio at its current weight.  I believe regenerative medicine to be the wave of the future and PSTI is positioned well to capitilize on the stem cell market.
 
===========================================================
 
DIVIDEND and PERFORMANCE Highlights:
Portfolio was up 0.86% in September, underperforming the S&P by (-2.12%) 
Total dividends for September are $194.40, up 32.2% YoY 
Total dividends for 2013 are $1,724.56. ... up 28.1% YoY through September.
Dividend Raises!
PM increase of 10.6% this month from 0.85/qtr to 0.94/qtr
MCD increase of 5.2% this month from 0.81/qtr to 0.77/qtr
==============================================================
SEPTEMBER 2013 DIVIDENDS RECEIVED:
TAXABLE ACCOUNT: (Dividends Reinvested)
Walmart (WMT) …….….… $21.94…..bot 0.301 shs
Pfizer (PFE) ………...….… $27.15…..bot 0.963 shs
Southern Co (SO) …..….… $22.84…..bot 0.560 shs
Chevron (CVX) ………….… $20.84…..bot 0.171 shs
CSX Corp (CSX) ….…….… $22.44…..bot 0.872 shs
McDonalds (MCD) ……….  $29.02…..bot 0.297 shs
Mattel (MAT) ………...….… $37.92…..bot 0.882 shs
Qualcomm (QCOM)...….… $12.25…..bot 0.179 shs
ROTH IRA: (Dividends Reinvested)
None
===========================================================
DIVIDEND PORTFOLIO HOLDINGS:
Symbol ….. Shares ... Mkt Value ... Total Divs… Gain/Loss 
AAPL ……. 5.264 .….. 2,509.37 ….  44.61 ……... 7.0%
T     ……..  86.96 .….. 2.940.95 ….  282.97 …….. 29.9%
BUD …….. 25.00 .….. 2,480.00 ….  69.37 ……... 106.0%
CVX …….. 21.01 ..…. 2,552.59 ….  147.67 …….. 36.8%
CSX …….. 150.50 .... 3,873.79 ….  126.72 …….. 27.6%
MAT …….. 106.22 …. 4,448.28 ….  419.44 …...   105.9%
MCD …….. 37.98 .….. 3,653.95 ….  427.69 ……. 72.4%
MFA …….. 325.22 ....  2,422.92 ….  154.62 ……  (-0.7%)
OXY …….. 20.30 .….. 1,898.77 ….  25.70 ……...  11.0%
PFE …….. 114.09 .…. 3,277.29 …. 313.57 …….. 77.5%
PM   …….. 35.57 .….. 3,079.75 ….  130.09 …….. 19.1%
QCOM…… 35.18 .….. 2,368.25 ….  12.25 ……..   10.0%
SO   …….. 85.56 .….. 3,523.36 ….  22.84 ……..   (-3.6%)
TGH  …….. 85.00 .….. 3,218.95 …. 147.45 ……..  8.2%
VOD …….. 84.39 .….. 2,968.95 ….  204.95 …….. 37.3%
WMT …….. 46.95 .….. 3,474.71 ….  234.36 …….. 54.1%
-------------------------------------------------------------------------------
Dividend Account Value …………....... $48,691.89
GROWTH HOLDINGS:
Symbol ...... Shares …... Mkt Value ….. Gain/Loss 
ATRS call …  40.00  …...  -800.00  …... 48.9% (19-Oct-13, Strike 5, wrote @ 0.25, 5.7% yield @ purch)
AAPL  …..…  15.00  …...  7,151.25  ..… 16.8%
ATRS …..…  4500.00  .... 18,270.00  … 16.1%
AMRN …..…  600.00  ..... 3,792.00  …. (-31.7%)
PSTI  …..…   800.00  ….. 2,704.00  .....  5.5%
ACTC  ....…  8500.00  ….. 603.50  …… (-34.0%)
----------------------------------------------------------------------------------
Growth Account Value ………………... $31,720.75
----------------------------------------------------------------------------------
CASH ….………………………….….… $1,827.43
-------------------------------------------------------------------------------
Trading and IRA Account Value ...... $82,240.75
=======================================================
401K Plan - my firm, at its discretion, may match dollar for dollar up to 4% of my salary
Notes for September: no changes this month, I plan to resist timing the market in the event of a pullback.
Allocations
Target Retirement 30%
Fixed Income 0%
US Equity 60% (5% REITs)
International Equity 10%
---------------------------------------------------------------------------------
401K Account Value …...................... $114,726.35
-------------------------------------------------------------------------------
Total Portfolio Value ………........ $196,969.88
=========================================================
SOLD POSITIONS - REALIZED GAINS/LOSSES (starting Jan 2013):
DIVIDEND GROWTH
Company ….. Date ..... Gain/Loss ……G/L %....... Reason/Result
BUD …….. 7/31/13 ….. 1,370.78. …… 91.9% …. Reducing to 3% wgt, raised cash for SO purch
MFA …….. 6/24/13 …. 1,004.50 ……. 44.7% …. Swapping MFA into Roth IRA account
BUD…….. 6/17/13 …. 1,144.36 ……. 88.0% …. Reducing overweight, buy QCOM for tech exposure
PFE……... 4/2/13 ……. 566.61 …….  83.8% …. Reducing overweight, no trade identified
T   …….... 2/19/13 …... 502.55 ……. 44.7% …. Reducing overweight, buy OXY for energey exposure
NLY …….  2/12/13 …… 73.88 ……… 5.9 % …. Reducing mREIT exposure, adding to ATRS position
GROWTH and SPECULATIVE
Company ….. Date ..... Gain/Loss ……G/L %....... Reason/Result
ATRS call ……. 8/19/13 …. 781.98 ….. n/a …. Covered call, expired worthless (yield 4.9% at purch)
ATRS call ……. 6/22/13 …. 381.99 ….. n/a …. Covered call, expired worthless (yield 2.5% at purch)
PSTI call …….. 3/16/13 ….. 76.39 ……. n/a …. Covered call, expired worthless (yield 3.0% at purch)
------------------------------------------------------------------------------
Total Cash Gains ... $5,903.04

No comments:

Post a Comment